These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 32519877

  • 1. Impact of Pre-Existing or Induced Anti-PEG IgM on the Pharmacokinetics of Peginterferon Alfa-2a (Pegasys) in Mice.
    Elsadek NE, Hondo E, Shimizu T, Takata H, Abu Lila AS, Emam SE, Ando H, Ishima Y, Ishida T.
    Mol Pharm; 2020 Aug 03; 17(8):2964-2970. PubMed ID: 32519877
    [Abstract] [Full Text] [Related]

  • 2. Pegfilgrastim (PEG-G-CSF) induces anti-PEG IgM in a dose dependent manner and causes the accelerated blood clearance (ABC) phenomenon upon repeated administration in mice.
    Elsadek NE, Lila ASA, Emam SE, Shimizu T, Takata H, Ando H, Ishima Y, Ishida T.
    Eur J Pharm Biopharm; 2020 Jul 03; 152():56-62. PubMed ID: 32376372
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Dose-Dependent Production of Anti-PEG IgM after Intramuscular PEGylated-Hydrogenated Soy Phosphatidylcholine Liposomes, but Not Lipid Nanoparticle Formulations of DNA, Correlates with the Plasma Clearance of PEGylated Liposomal Doxorubicin in Rats.
    Subasic CN, Butcher NJ, Minchin RF, Kaminskas LM.
    Mol Pharm; 2023 Jul 03; 20(7):3494-3504. PubMed ID: 37256791
    [Abstract] [Full Text] [Related]

  • 5. A hydroxyl PEG version of PEGylated liposomes and its impact on anti-PEG IgM induction and on the accelerated clearance of PEGylated liposomes.
    Shimizu T, Abu Lila AS, Fujita R, Awata M, Kawanishi M, Hashimoto Y, Okuhira K, Ishima Y, Ishida T.
    Eur J Pharm Biopharm; 2018 Jun 03; 127():142-149. PubMed ID: 29462689
    [Abstract] [Full Text] [Related]

  • 6. Impact of anti-PEG IgM antibodies on the pharmacokinetics of pegylated asparaginase preparations in mice.
    Poppenborg SM, Wittmann J, Walther W, Brandenburg G, Krähmer R, Baumgart J, Leenders F.
    Eur J Pharm Sci; 2016 Aug 25; 91():122-30. PubMed ID: 27292820
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Anti-PEG IgM production and accelerated blood clearance phenomenon after the administration of PEGylated exosomes in mice.
    Emam SE, Elsadek NE, Abu Lila AS, Takata H, Kawaguchi Y, Shimizu T, Ando H, Ishima Y, Ishida T.
    J Control Release; 2021 Jun 10; 334():327-334. PubMed ID: 33957196
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A mouse model for studying the effect of blood anti-PEG IgMs levels on the in vivo fate of PEGylated liposomes.
    El Sayed MM, Shimizu T, Abu Lila AS, Elsadek NE, Emam SE, Alaaeldin E, Kamal A, Sarhan HA, Ando H, Ishima Y, Ishida T.
    Int J Pharm; 2022 Mar 05; 615():121539. PubMed ID: 35124114
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Ex-vivo/in-vitro anti-polyethylene glycol (PEG) immunoglobulin M production from murine splenic B cells stimulated by PEGylated liposome.
    Abu Lila AS, Ichihara M, Shimizu T, Ishida T, Kiwada H.
    Biol Pharm Bull; 2013 Mar 05; 36(11):1842-8. PubMed ID: 24189428
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.